# Dexmedetomidine Dose-Dependent on Lung Function and AQP1 in One-Lung Ventilation Surgery

> **NCT07145814** · NA · COMPLETED · sponsor: **People's Hospital of Guangxi Zhuang Autonomous Region** · enrollment: 60 (actual)

## Conditions studied

- Acute Lung Injury(ALI)

## Interventions

- **DRUG:** dexmedetomidine 0.3 µg/kg/h
- **DRUG:** dexmedetomidine 0.5 µg/kg/h
- **DRUG:** 0.9 % saline

## Key facts

- **NCT ID:** NCT07145814
- **Lead sponsor:** People's Hospital of Guangxi Zhuang Autonomous Region
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-05
- **Primary completion:** 2019-03-29
- **Final completion:** 2019-03-29
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07145814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07145814, "Dexmedetomidine Dose-Dependent on Lung Function and AQP1 in One-Lung Ventilation Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07145814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*